Incidence, Source, Determinants, and Prognostic Impact of Major Bleeding in Outpatients With Stable Coronary Artery Disease-Reference-Cited by-同舟云学术

Incidence, Source, Determinants, and Prognostic Impact of Major Bleeding in Outpatients With Stable Coronary Artery Disease

Published:2014-10 Issue:14 Volume:64 Page:1430-1436
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Hamon Martial,Lemesle Gilles,Tricot Olivier,Meurice Thibaud,Deneve Michel,Dujardin Xavier,Brufau Jean Michel,Bera Jerome,Lamblin Nicolas,Bauters Christophe

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes;Rao;Am J Cardiol,2005

2. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes;Eikelboom;Circulation,2006

3. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology;Steg;Eur Heart J,2011

4. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions;Kinnaird;Am J Cardiol,2003

5. Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention;Verheugt;J Am Coll Cardiol Intv,2011

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with Atrial Fibrillation are Unlikely to Benefit from Aspirin Monotherapy;International Journal of General Medicine;2024-05

2. The ABCs of the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease;Clinical Cardiology;2024-05

3. Cardiovascular medications used for comorbid diseases in patients with atrial fibrillation. The JoFib study;European Journal of Clinical Pharmacology;2024-01-23

4. Optimal Antithrombotic Therapy Beyond 1-Year After Coronary Revascularization in Patients With Atrial Fibrillation;Journal of Korean Medical Science;2024

5. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2023-08-29